[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 2.56% 16.00 16.00 16.25 16.125 15.625 15.63 2,880,544 16:35:22
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 10.4 -6.3 -1.5 - 69

Kromek Share Discussion Threads

Showing 5526 to 5547 of 6050 messages
Chat Pages: Latest  230  229  228  227  226  225  224  223  222  221  220  219  Older
DateSubjectAuthorDiscuss
26/10/2021
18:02
Kromek really need to focus on delivering the results and sales of the biological pathogen detector. That is what they primarily based the £13m fundraising on. If they have any respect at all for investors who contributed to that £13m they will offer an update. Distractions of ‘upto’ contracts won’t cut it. Nor will pathetic buys of £15k by board members. Kromek - you are entering the end of the road of investors patience. I’m still holding some - but all the warning signs on the dashboard are screaming sell
aqc888
26/10/2021
17:51
What has the result of your journey been? “It’s been an 18-year journey. We did our first acquisition of a Californian business in 2010. We had our first major US government contract in 2008 and we acquired a second US company in 2013, and then listed on the UK AIM market in the same year.” And since the IPO THAT YEAR THE Sp HAS BEEN ON A CONSTANT DOWNWARD TREND! With the exception of a few spikes when insiders and MMs have made some dosh.
b00mb0y
26/10/2021
17:48
Arnab giving advice on commercialization when he delivered 75% loss to shareholders and endless dilution over 8 years? "What tips would you give to businesses developing commercial services underpinned by physics and requiring innovation?" "Customers and your own people are at the heart of any strategy; understand the market and look after your cash. Commercialisation is a multifaceted process: science and technology play a part, but at the heart of that process are people. Then there is the market. You need to understand whether the market exists for the technology that you’re trying to apply. People often make a mistake when looking for a gap in the market as there are lots of obvious gaps, but the important thing to understand is whether that gap needs to be filled: is there a market for it?"
ark87
26/10/2021
17:46
All should remember that Kromeks order book is 75% full for this year’s analysts forecasts. This order which ‘might’ make up some of this years forecast still doesn’t reach what’s expected of Kromek in this financial year. Given they have a few more months to make up the rest, but it’s hardly an announcement they are thrashing this years forecasts. Personally I’m extremely frustrated at the opaqueness regarding the biological pathogen detectors results and sales. Who tested the detectors in the accredited tests - unknown. What exactly were the results to these tests other than really good.. - unknown. Have any of the testing partners made comments/indications they want to buy any - unknown. How’s the commercialisation going - unknown. But hey guys we got another ‘up to’ order again. None of the other ‘upto’ orders ever materialised. Kromeks attitude to investors is treat them like mushrooms- keep them in the dark and sh*t on them from time to time. It’s not going to work for much longer Kromek. Get serious or your going bankrupt next time you need a fundraising. Deservedly so. Give us the details you promised months ago. Nobody is interested nor getting distracted by any more games till you give details and sales on the biological pathogen detectors.
aqc888
26/10/2021
16:50
Not seen this article before, and can't see a date when written, week on my mobile anyway. Case study: Kromek | Institute of Physics hTTps://www.iop.org/strategy/productivity-programme/innovation-survey/kromek#gref
33mick
26/10/2021
14:36
Proves product and opens to world wide markets is the thing here - exciting
strategicinvestor2
26/10/2021
14:27
Strategicinvestor2 - Isnt "£0.9m to the bottom line every year" the best case scenario with the worst case scenario being near nothing but the reality probably somewhere in between? It's a good RNS but still small potatoes?
ark87
26/10/2021
14:15
edmonda It's not a 7 year $17m contract. read it again and work out why it says "UP TO" It's a small sale to a large US OEM which, IF they like it, they will buy some more each year.
bosbus
26/10/2021
10:52
There is simply no respect from shareholders anymore no matter how good an RNS may read. This is due to years of promises and years of letdowns. The little rise so far today is perfectly in line with the last 3 months trend line. Kmk sucks.
b00mb0y
26/10/2021
10:06
Exactly £0.9m to bottom line every year is excellent news - suspect will be a very prudent estimate as only single roll out IHMO DYOR
strategicinvestor2
26/10/2021
09:31
£17m contract. From memory the broker says Kromek works on a 52% profit. That’s £6m profit over 7years?!?! Or is the little boy who cried wolf at it again? Kromek up 0.6% on news of a huge additional yearly profit for 7years. Will probably be in negative territory by the end of the day. The management have zero credibility. Professional investors don’t believe it. Increasingly small investors don’t believe any of it. And most devastatingly the founder and CEO doesn’t believe any of it with his 0.86% holding.
aqc888
26/10/2021
09:04
Excellent news today - celebrate
strategicinvestor2
26/10/2021
08:40
Indeed; continued vague RNS details & still no update on sales of the covid detector! No surprise to usual share price performance on news releases. Disappointing!
davethechef
26/10/2021
08:00
Much as I need the share price to rise, this is not yet a 17m contract and QP is spot on. I've been holding for years and "up to" is not the proper way to report a contract. If you buy a lottery ticket you can win up to many millions but you probably won't
bosbus
26/10/2021
07:53
So we can expect a small bump up in the share price but end up down at market close today. Just saying……
b00mb0y
26/10/2021
07:44
“They need to say who the counterparty is” Why? Are some $ worth more than other $? Also, if you can sell it once, you can sell it again. Obviously there’s a finite market but the company they sold to will have competitors or at least peers so there’s more chance of further sales.
mauricemonkey
26/10/2021
07:30
7 year, US based contract and the usual suspects are shouting about credibility!!...irony anyone?
dexter1612
26/10/2021
07:07
Should see nice rise to 20p plus hopefully in coming days… IMHO DYOR
strategicinvestor2
26/10/2021
07:00
keep trying. Who cares this is a new contract and new revenue. Took your short by surprise?
babbler
26/10/2021
06:59
Yawn. What happened to the ventilators? What happened to the covid-sniffer-thingamajig?? What happened to the 4/4/14 UP TO $159m 7 year contract??? If they want to add credibility, they need to say who the counterparty is and how much the initial order is for. ALL IMO. DYOR. QP
quepassa
26/10/2021
06:50
Fantastic contract - well done all at Kromek
strategicinvestor2
26/10/2021
06:29
This books revenue for years. Exactly what an acquirer will be looking for. AIMHO GLA BTG
btgman
Chat Pages: Latest  230  229  228  227  226  225  224  223  222  221  220  219  Older
ADVFN Advertorial
Your Recent History
LSE
KMK
Kromek
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220122 00:58:40